Drugs / Diphtheria, Tetanus, Pertussis (DTaP) Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04636827 Comparator | Nov 2020 → Aug 2021 | — | China National Biotec Group Company Limited | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, Tetanus, Pertussis (DTaP) Vaccine | “Diphtheria, Tetanus, Pertussis (DTaP) Vaccine” NCT04636827 ↗ |
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04636827 ↗ |